Trial intelligence / Profile preview

Cord blood platelet gel for hand burn ulcer treatment

IRCT20141007019432N4Phase 3Completed

Sponsor
Vice Presidency for Science and Technology
Start
Mar 2018
Modality
Cell Therapies
Countries
1
01

Overview

Phase 3, open-label trial of cord blood platelet gel in burn injury and Cutaneous ulcer (2 arms), sponsored by Vice Presidency for Science and Technology. Primary endpoints: Surface area of granulation tissue, Healing time and 1 more. Started Mar 2018; status: completed.

02

Drugs

cord blood platelet gel
03

Conditions

burn injuryCutaneous ulcer

Beyond the preview

Go deeper on IRCT20141007019432N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141007019432N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call